
{{Infobox medical condition|name=Coronavirus disease 2019<br />(COVID-19)|types=|frequency=<!--Total cases since discovery till a yearly figure emerges.-->{{Cases in 2019–20 coronavirus outbreak|confirmed}} confirmed cases|prognosis=|medication=|treatment=[[Symptomatic treatment|Symptomatic]] and [[supportive treatment|supportive]]|prevention=frequent [[hand washing]], cough etiquette, [[quarantine]] of infected people and at-risk populations, [[social distancing|physical distancing]]|differential=|diagnosis=[[Reverse transcription polymerase chain reaction|rRT-PCR testing]], [[immunoassay]], [[CT scan]]|risks=Travel, exposure to the virus|cause=[[Severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2)|duration=|synonyms=* 2019-nCoV acute respiratory disease 
* Novel coronavirus pneumonia<ref name="NHC2020Name">{{Cite web|url=http://www.nhc.gov.cn/yzygj/s7653p/202002/18c1bb43965a4492907957875de02ae7.shtml|script-title=zh:国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知 |publisher=[[National Health Commission]] |language=zh-cn |date=7 February 2020 |url-status=dead|archive-url=https://archive.today/20200228040516/http://www.nhc.gov.cn/yzygj/s7653p/202002/18c1bb43965a4492907957875de02ae7.shtml|archive-date=28 February 2020|access-date=9 February 2020| name-list-format = vanc}}</ref>
* Wuhan pneumonia<ref name=TIMEinfo>{{cite web | first = Charlie | last = Campbell | name-list-format = vanc | title = The Wuhan Pneumonia Crisis Highlights the Danger in China's Opaque Way of Doing Things | date = 20 January 2020 | access-date = 13 March 2020 | url = https://time.com/5768230/wuhan-pneumonia-flu-crisis-china-government/ | work = [[Time (magazine)|Time]] }}</ref><ref name=FPinfo>{{cite web | first1 = Daniel | last1 = Lucey | first2 = Annie | last2 = Sparrow | name-list-format = vanc | title = China Deserves Some Credit for Its Handling of the Wuhan Pneumonia | date = 14 January 2020 | access-date = 13 March 2020 | url = https://foreignpolicy.com/2020/01/14/china-response-wuhan-pneumonia-better-sars/ | work = [[Foreign Policy]] }}</ref>
*Wuhan coronavirus
* "Coronavirus" or other names for [[SARS-CoV-2]]|onset=|complications=[[Viral pneumonia|Pneumonia]], [[acute respiratory distress syndrome]], [[Acute kidney injury|kidney failure]]|symptoms=Fever, cough, shortness of breath<ref name="CDC2020Sym"/>|specialty=[[Acute respiratory infection]]<ref>See [[SARS-CoV-2]] for more.</ref>|pronounce={{IPAc-en|k|ə|ˈ|r|oʊ|n|ə|ˌ|v|aɪ|r|ə|s|_|d|ɪ|ˈ|z|i:|z|,_|ˈ|k|oʊ|v|ɪ|d}}|caption=Symptoms of COVID-19|alt=COVID-19 symptoms|width=|image=Symptoms of coronavirus disease 2019 2.0.svg|deaths={{Cases in 2019–20 coronavirus outbreak|deaths}} (4.5% of confirmed cases)<ref name="worldometers.info"/>}}'''ယဲကဝ်ရဝ်နာဝဳရုသ် (ကဝ်ဝိဒ်-၁၉) (Coronavirus disease 2019''' ('''COVID-19''')) ဝွံ ဒှ်ယဲကၞာန် ဟိုတ်နူကဵု (SARS-CoV-2).<ref>{{Cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|title=Naming the coronavirus disease (COVID-19) and the virus that causes it|publisher=[[World Health Organization]] (WHO)}}</ref> ယဲဏအ်ဂှ် ဗွဲကိုပ်ကၠာ ဂွံတီကေတ် ပ္ဍဲသၞာံ ၂၀၁၉ ပ္ဍဲဝူဟာန်၊ ဍုင်ဇၞော် တွဵုရးဟူဗေ၊ ဍုင်ကြုက်တုဲ နူဂှ် ကၠောအ်ကၞာန်အာ အလုံလိုက်တုဲ ဒှ်အာ ၂၀၁၉-၂၀ ကဝ်ရဝ်နာဝဳရုသ် ကပ်ယဲ (2019–20 coronavirus pandemic)ရ။<ref name="Hui14Jan2020">{{Cite journal|title=The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China}}</ref> လက်သန်ယဲ ၜိုတ်မတီစၟတ်သမ္တီလဝ် လၟုဟ်မ္ဂး ဇကုကတဴ၊ ခဍက် ကေုာံ ယဲဂြက်။ ဂိဇကုဇကောဝ် (Muscle pain)၊ လှေဟ် တိတ် (sputum production)၊ ဂၞဴလီု ( diarrhea)၊ ကအ်ဂိတ (sore throat) ကေုာံ ကအ်လီု (loss of taste) ကေုာံ/ဟွံသေင်မ္ဂး (loss of smell) တအ်ဂှ်လေဝ် ဒှ်လက်သန်ယဲဏအ် နွံကီုရ။<ref>{{Cite web|url=https://www.independent.co.uk/life-style/health-and-families/coronavirus-symptoms-respiratory-anosmia-smell-taste-loss-ent-asymptomatic-a9418151.html|title=CORONAVIRUS: WHY ARE LOSS OF SMELL AND TASTE REPORTEDLY SYMPTOMS OF COVID-19?|publisher=The Independent}}</ref><ref name="CDC2020Sym">{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Coronavirus Disease 2019 (COVID-19) Symptoms}}</ref><ref name="whoqa">{{Cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses (COVID-19)|publisher=[[World Health Organization]] (WHO)}}</ref><ref name=":11">{{Cite journal|title=COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission}}</ref><ref name=":12">{{Cite journal|title=Panic of Buying Toilet Papers: A Historical Memory or a Horrible Truth? Systematic Review of Gastrointestinal Manifestations of COVID-19}}</ref> မၞိဟ်ဗွဲမဂၠိုင်တအ်ဂှ် လက်သန်ယဲ ဆညိညဟေင်ထ္ၜးတုဲ <ref>{{Cite news|url=https://www.nytimes.com/2020/02/27/world/asia/coronavirus-treament-recovery.html|title=Most Coronavirus Cases Are Mild. That's Good and Bad News.}}</ref> ညးလ္ၚဵုတအ်ဂှ် ဗဒှ်ကဵု ယဲကသအ် (ယီုဟွံဂွံ) (pneumonia) ကေုာံ ယဲအဝဲခန္ဓအပ္ဍဲ-နာနာ သရိုဟ်လီု  (multi-organ failure)။<ref name="WHO-q-a">{{Cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses}}</ref> စဵုကဵု ၂၅ မာတ် ၂၀၂၀ လၟိဟ် ဂမ္စိုတ် ညးမဒှ်ယဲဏအ်ဂှ် ဒှ် ၄.၅ တၟအ်ကၠံ (ပ္ဍဲမၞိဟ် မဒှ်ယဲဏအ် ကၠံတၠဂှ် မၞိဟ် ပန်ကဝက်တၠ ဒးချိုတ်)၊ ဆဂး နူကဵု ၀.၂ တၟအ်ကၠံ စဵုကဵု ၁၅ တၟအ်ကၠံ ဒှ်မာန်ရ။ တန်တဴဒၟံင်ကဵု အာယုက် ကေုာံ ပရေင်ထတ်ယုက် ညးကမၠောအ်ယဲတအ်ရ။ အာယုက်ဍောတ်၊ ပရေင်ထတ်ယုက်ခိုဟ်မ္ဂး ဂွံဗၠးဂှ် အခေါင်နွံဂၠိုင်ရ။ <ref name="worldometers.info">{{Cite web|url=https://www.worldometers.info/coronavirus/coronavirus-death-rate/|title=Coronavirus (COVID-19) Mortality Rate}}</ref>

ဝဳရုသ်ဏအ်ဂှ် ဗွဲမဂၠိုင် ကၠောအ်ကၞာန် ဟိုတ်နူကဵု စုက်လုက်ကြပ်ပ် နူကဵု ထၞဟ်ပၞောက်ယဝီု (respiratory droplets) ကာလမၞိဟ်မနွံကဵုယဲ ခအဟ် ဟွံသေင်မ္ဂး ကသိုဟ်။ ထၞဟ်တအ်ဂှ် ဍောတ်သောဲ ရံင်ကဵုမတ် ဆဵုကေတ် ဟွံမာန်ကီုလေဝ် ဝဳရုသ်ဗွဲမဂၠိုင် နွံမာန်ရ။ ထၞဟ်ပၞောက်ယဝီုဂှ် ကာလမယီုကျာလေဝ် တိတ်ဒၟံင်ကီုရ၊ ဆဂး ထၞဟ်(ဝဳရုသ်)တအ် ဍေဟ် ဟွံပြးတိတ်အာ အပ္ဍဲကဵုကျာရ။ နကဵု မရပ်ဒး မုက်ညးမနွံကဵုယဲတအ်တုဲ နကဵုတဲဂှ် ဇကုကလေင်ရပ် မုက်ဇကုမ္ဂးလေဝ် ယဲကၠောအ်မာန်ကီုရ။ အခိင်မၞိဟ်ယဲ မနွံကဵု လက်သန်ယဲဂှ် ကၠောအ်လောဲသွာကီုလေဝ်၊ အခိင်မနွံကဵု ဝဳရုသ် မဟွံထ္ၜး လက်သန်ယဲဏီဂှ်လေဝ် ကၠောအ်မာန်ကီုရ။ ဝဳရုသ်ဂှ် ပ္ဍဲကဵု မုက်မၞိဟ် စဵုကဵု ပွိုင် ၇၂ နာဍဳ ဂျိုင်မာန်ရ။ အခိင်ကာလ နူစ မဒးဒုင်ကၠောအ် စဵုကဵု လက်သန်ယဲမံက်ဂှ် ဗွဴမဂၠိုင် နွံ အကြာ ၜါတ္ၚဲ ကဵု ၁၄ တ္ၚဲ၊ ဗွဲသၟဟ်မ္ဂး နွံ ၅ တ္ၚဲရ။ နဲကဲ မစမ်ၜတ်ယဲ သွက်ဂွံတီကေတ် ယဲဏအ်မာန်ဂှ် စကာ နကဵု နဲကဲ reverse transcription polymerase chain reaction (rRT-PCR) နူကဵု ဍာ်မုဟ် ဍာ်ပါင်ရ။ နကဵု နဲကဲ မဗှ်သကေန် ပ္ဍဲကဵု ကသအ်မၞိဟ်ယဲလေဝ် ဂွံတီကေတ် ယဲဏအ်မာန်ကီုရ။

နဲကဲ မကဵုလဝ်သမ္တီ သွက်ဂွံစဵုဒၞာ ညံင်ယဲဟွံကၠောအ်ဂှ် ကြာတ်တဲ၊ လ္ပမံင်ကြပ်ပ် ရေင်သကအ် (ဗွဲတၟေင် ကုမၞိဟ် မနွံကဵု ဝဳရုသ်တအ်ဂှ် ဒးဝေင်ပါဲ မံင်သ္ၚောဲသ္ၚောဲ၊ ကာလခ္ဍက်၊ ခအဟ်မ္ဂး ကၟာတ် နကဵု စက္ခောတိသ်ရှူ ဟွံသေင်မ္ဂး ယာတ်၊ တဲဟွံဂွံကြာတ်လဝ်ဏီဂှ် စွံသ္ၚောဲသ္ၚောဲ ကုမုက်။<ref name="Advice for public">{{Cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|title=Advice for public}}</ref><ref>{{Cite web|url=https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|title=Guidance on social distancing for everyone in the UK}}</ref> စကာမုက် ယာတ်ကၟာတ်မုဟ်ပါင်ဂှ် ပ္ဍဲဌာနအဝဵုအသဳ ပရေင်ထတ်ယုက် ဍုင်လ္ၚဵုတအ် ကဵုစကာတုဲ ဍုင်လ္ၚဵုတအ်ဂှ် သွက်ညးမယဲ ကေုာံ သံသယယဲ ကေုာံ ကောန်ကမၠောန် ပရေင်ထတ်ယုက်တအ်ဟေင် စကာရ။<ref name="CDC2020IfSick">{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html|title=2019&nbsp;Novel Coronavirus (2019-nCoV)}}</ref><ref>{{Cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|title=Advice for public}}</ref> ဂဥုဲဝက်သေန် (ဂဥုဲစဵုဒၞာ) ကေုာံ ဂဥုဲဂစိုတ်ဝဳရုသ် သွက်ဂွံလွဳ ယဲကဝ်ဝိဒ်-၁၉ဂှ် ဟွံမဲဏီရ။ လွဳလွတ်ဒၟံင် နကဵုလက်သန်ယဲ ညံင်မၞိဟ်ယဲ ဂွံမံင်လောဲတုဲ နကဵုဒြဟတ်ဒုင်ဗတဝ် မၞိဟ်ယဲဂှ် ညံင်ဂွံဗၠးအာ ကေတ်တ်ဟေင်ရ။<ref name="cdc21Jan20202">{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html|title=Coronavirus Disease 2019 (COVID-19)}}</ref>

ဂကောံပရေင်ထတ်ယုက် ဂၠးကဝ် (WHO) လလောင်တြးလဝ် ဒဒှ်ရ ၂၀၁၉-၂၀ ယဲကဝ်ရဝ်နာဝဳရုသ် ဂှ် ဒှ်ယဲမဒှ်ဓဝိင် ဍုင်နာနာ ပရေင်ထတ်ယုက် ညးဍုင်ကွာန်  Public Health Emergency of International Concern (PHEIC) ပ္ဍဲကဵု ၃၀ ဇာန်နဝါရဳ ၂၀၂၀ ဂှ်၊<ref>{{Cite web|url=https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)|title=Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)}}</ref><ref>{{Cite news|url=https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/02/05/114ced8a-479c-11ea-bc78-8a18f7afcee7_story.html|title=Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China}}</ref> နူဂှ် နဒဒှ် ယဲကပ် ([[ကပ်|pandemic]]) ပ္ဍဲကဵု ၁၁ မာတ် ၂၀၂၀။ ယဲဝွံ ကတဵုဒှ်ဒၟံင် ပ္ဍဲဍုင်ဗွဲမဂၠိုင် ပ္ဍဲကဵု တိုက် ၆ မဒှ် ဒေသ မပါ်လဝ် နကဵု ဂကောံပရေင်ထတ်ယုက်ဂၠးကဝ်ဂှ်ရ။<ref>{{Cite web|url=ho.int/docs/default-source/coronaviruse/situation-reports/20200325-sitrep-65-covid-19.pdf|title=WHO Situation Report #65}}</ref>

== အကာဲအရာ ကေုာံ လက်သန်ယဲ ==
{| class="wikitable" style="float:right; margin-left:1em; text-align:center"
!လက်သန် Symptom
!%
|-
|ဂမ္တဴ <br>(Fever)
|87.9
|-
|ခ္ဍဟ်ဇမ္ကဟ် <b>(Dry cough)
|67.7
|-
|ဒြဟတ်အိုတ်<b> (Fatigue)
|38.1
|-
|သလေဟ်တိတ် <br>(Sputum production)
|33.4
|-
|သၟူ ကေုာံ ရှ် လီု <br>(Loss of smell and taste)<ref name="entuk-anosmia">{{Cite web|url=https://www.entuk.org/loss-sense-smell-marker-covid-19-infection|title=Loss of sense of smell as marker of COVID-19 infection|last=|first=|date=}}</ref><ref name="entnet-anosmia">{{Cite web|title=Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease|url=https://www.entnet.org/content/coronavirus-disease-2019-resources|date=22 March 2020}}</ref>
|30 to 66
|-
|ယီုဝါတ် <br>(Shortness of breath)
|18.6
|-
|ဂိ ဇကုဇကောဝ် ဟွံသေင်မ္ဂး ပ္ၚပ်ဇိုင်တဲ <br>(Muscle or joint pain)
|14.8
|-
|ကအ်ဂိ <br>(Sore throat)
|13.9
|-
|က္ဍိုပ်ဂိ <br>(Headache)
|13.6
|-
|ဂံက် <br>(Chills)
|11.4
|-
|စံင်ပရံင် ပေင်သြိုဟ်<br> (Nausea or vomiting)
|5.0
|-
|ဍာ်မုဟ်ဓဇူ <br>(Nasal congestion)
|4.8
|-
|ဂၞဴအာ <br>(Diarrhea)
|3.7 to 31<ref name=":10">{{Cite book|last=Wei|first=Xiao-Shan|date=26 February 2020|title=Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea}}</ref>
|-
|ခ္ဍက်ဆီ <br>(Haemoptysis)
|0.9
|-
|မတ်ဍာဲ <br>(Conjunctival congestion)
|0.8
|}
ကုညးမဒးဒုင်ကၠောအ် ကုဝဳရုသ်ဏအ်မ္ဂး လက်သန်ယဲ ကတဵုဒှ် ညံင်ရဴ ညးမဒှ် ယဲဆီု၊ ဗီုကဵု ဇကုကတဴ၊ ခ္ဍက်၊ ဒြဟတ်အိုတ် ကေုာံ ယဲဝါတ်ရ။<ref name="CDC2020Sym">{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Coronavirus Disease 2019 (COVID-19) Symptoms|date=10 February 2020}}</ref><ref name=":2">{{Cite journal|title=Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study|date=February 2020}}</ref><ref name="Hessen27Jan2020">{{Cite web|url=https://www.elsevier.com/connect/coronavirus-information-center|title=Novel Coronavirus Information Center: Expert guidance and commentary|date=27 January 2020}}</ref>လက်သန်ယဲ မကတဵုဒှ် မွဲတဲဓဝ် မကော်ဂး (Emergency symptoms) မပ္တံကဵု ပွမယီုဝါတ်၊ သြိုဟ်ဂိ ဟွံဒေါအ် ဟွံသေင်မ္ဂး ဒုင်စသိုင် ဖဍိုက်လဝ် ပ္ဍဲသြိုဟ်၊ ကွာ်ဝါတ်၊ ကေုာံ မုက် ကေုာံ သၟောန်ပါင်သ္ၚေက် (bluish face or lips) ယဝ်ရ လက်သန်ဗီုဏအ် ကတဵုဒှ်ကၠုင်မ္ဂး ညံင်ဂွံဂွံလွဳဗွဲမပြဟ်ဂှ် ကဵုလဝ် ဓဝ်သတိရ။<ref>{{Cite web|title=Coronavirus Disease 2019 (COVID-19)—Symptoms|url=https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html|date=20 March 2020}}</ref>ပါဲနူ လက်သန်ယဲ မဆေင်ကဵု ယဓီုတုဲ ဗီုကဵု ဒးဆီု၊ ခၟောဝ်ဓဇူ ဟွံသေင်မ္ဂး ကအ်ဂိတအ်လေဝ် ဂွံဆဵုကေတ်ကီုရ။ လက်သန်ယဲ မပ္တံကဵု စံင်ပရံင် ပေင်သြိုဟ် ကေုာံ ဂၞဴအာတအ်လေဝ် ဂွံဆဵုကေတ် နကဵုတၟအ်ကၠံ ညိညကီုရ။<ref name=":10">{{Cite book|date=26 February 2020|title=Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea|location=Rochester, NY}}</ref><ref name="Huang24Jan2020">{{Cite journal|title=Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China|date=February 2020}}</ref><ref>{{Cite journal|date=1 March 2020|title=Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges}}</ref>မၞိဟ်ယဲလ္ၚဵု ပ္ဍဲဍုင်ကြုက် စဒှ် မပ္တံကဵု သြိုဟ်ဂြက် (chest tightness) ကေုာံ ခတဝ် ပ္ဍဲကဵုသြိုဟ်တအ် ဂွံဆဵုကေတ်ကီုရ။<ref name="Zheng Ma Zhang Xie p.">{{Cite journal|title=COVID-19 and the cardiovascular system|date=March 2020}}</ref>မုဟ်လီု (ဟွံဂွံသၟူ) Anosmia (loss of the sense of smell) ကေုာံ ကအ်လီု (ဟွံဂွံရှ်) dysgeusia (distortion of the sense of taste) တအ်ဂှ်လေဝ် နွံကီုရ။ ဗွဲတၟေင် ကုညး မဟွံထ္ၜး လက်သန်ယဲတၞဟ်တအ် ဂွံဆဵုကေတ်ရ။<ref name="entuk-anosmia">{{Cite web|url=https://www.entuk.org/loss-sense-smell-marker-covid-19-infection|title=Loss of sense of smell as marker of COVID-19 infection|date=}}</ref><ref name="entnet-anosmia">{{Cite web|title=Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease|url=https://www.entnet.org/content/coronavirus-disease-2019-resources|date=22 March 2020}}</ref> ပ္ဍဲကဵု မၞိဟ်လ္ၚဵုဂှ် ယဲဂှ် ဒှ်အာယဲကသအ် (pneumonia)၊ ယဲအဝဲခန္ဓအပ္ဍဲ သရိုဟ်လီုတုဲ ချိုတ် (လဝုဲ)ဂှ်ရ။<ref name="Hui14Jan2020">{{Cite journal|title=The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China|date=February 2020}}</ref><ref name="WHO-q-a">{{Cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses}}</ref>

== ယဲ ==

The disease is [[Cause (medicine)|caused]] by the virus [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2), previously referred to as the 2019 novel coronavirus (2019-nCoV).<ref name="Gorbalenya-bioRxiv">{{cite journal |last=Gorbalenya |first=Alexander E. | name-list-format = vanc |date=11 February 2020 |title=Severe acute respiratory syndrome-related coronavirus—The species and its viruses, a statement of the Coronavirus Study Group |journal=[[bioRxiv]] |type=preprint |doi=10.1101/2020.02.07.937862 |doi-access=free }}</ref> It is primarily spread between people via respiratory droplets from [[cough]]s and [[sneeze]]s.<ref name="CDC2020Spread">{{cite web |title=2019&nbsp;Novel Coronavirus (2019-nCoV) |url=https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html |website=Centers for Disease Control and Prevention |access-date=18 February 2020 |date=11 February 2020 |archive-url=https://web.archive.org/web/20200307081351/https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html |archive-date=7 March 2020 |url-status=live |quote=The virus is thought to spread mainly from person-to-person ... through respiratory droplets produced when an infected person coughs or sneezes. }}</ref> A study investigating the rate of decay of the virus found no viable viruses after 4 h on copper, 24 h on cardboard, 72 h on stainless steel, and 72 h on plastic. However, detection rates did not reach 100% and varied between surface type (limit of detection was 3.33×10<sup>0.5</sup> [[Virus quantification|TCID<sub>50</sub>]] per liter of air for aerosols, 10<sup>0.5</sup> TCID<sub>50</sub> per milliliter of medium for plastic, steel, and cardboard, and 10<sup>1.5</sup> TCID<sub>50</sub> per milliliter of medium for copper). Estimation of the rate of decay with a Bayesian regression model suggests that viruses may remain viable up to 18 h on copper, 55 h on cardboard, 90 h on stainless steel, and over 100 h on plastic. The virus remained viable in aerosols throughout the time of the experiment (3 h).<ref name="van Doremalen Bushmaker Morris Holbrook p.">{{cite journal | vauthors = van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ | display-authors = 6 | title = Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 | journal = The New England Journal of Medicine | date = March 2020 | pmid = 32182409 | doi = 10.1056/nejmc2004973 | publisher = Massachusetts Medical Society }}</ref> The virus has also been found in [[Feces|faeces]], and [[fecal-oral route|transmission through faeces]] is being researched.<ref name=":11">{{Cite journal|last=Gu|first=Jinyang|last2=Han|first2=Bing|last3=Wang|first3=Jian|date=27 February 2020|title=COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission|journal=Gastroenterology|volume=|pages=|doi=10.1053/j.gastro.2020.02.054|pmid=32142785|issn=0016-5085}}</ref><ref>[https://www.cdc.gov/coronavirus/2019-ncov/php/water.html Water Transmission and COVID-19] (CDC, accessed 19 March 2020)</ref>

The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme [[angiotensin-converting enzyme 2|ACE2]], which is most abundant in the [[Pulmonary alveolus#Type II cells|type II alveolar cells]] of the lungs. The virus uses a special surface glycoprotein called a "spike" ([[peplomer]]) to connect to ACE2 and enter the host cell.<ref name="Nature Microbiology">{{cite journal | title=Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses | journal=Nature Microbiology | doi=10.1038/s41564-020-0688-y | doi-access=free | pmid=32094589 | year=2020 | vauthors=Letko M, Marzi A, Munster V | pages=1–8 }}</ref> The density of ACE2 in each tissue correlates with the severity of the disease in that tissue and some have suggested that decreasing ACE2 activity might be protective,<ref name="Zhang Penninger Li Zhong p.">{{cite journal | vauthors=Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS | title=Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | journal=Intensive Care Medicine | date=March 2020 |doi=10.1007/s00134-020-05985-9 | doi-access=free | pmid=32125455 }}</ref><ref name="Xu Zhong Deng Peng p.">{{cite journal | vauthors=Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q | display-authors=6 | title=High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa | journal=International Journal of Oral Science | volume=12 | issue=1 | pages=8 | date=February 2020 | doi=10.1038/s41368-020-0074-x |doi-access=free | pmid=32094336 | pmc=7039956 }}</ref> though another view is that increasing ACE2 using [[angiotensin II receptor blocker]] medications could be protective and that these hypotheses need to be tested.<ref>{{cite journal | vauthors=Gurwitz D | title=Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics | journal=Drug Development Research | doi=10.1002/ddr.21656 | doi-access=free | pmid=32129518 | date=March 2020 }}</ref> As the alveolar disease progresses, respiratory failure might develop and death may follow.<ref name="Xu Zhong Deng Peng p."/>

The virus also affects gastrointestinal organs as ACE2 is abundantly expressed in the [[Gland|glandular]] cells of [[Stomach|gastric]], [[Duodenum|duodenal]] and [[Rectum|rectal]] [[epithelium]]<ref name=":11" /> as well as [[Endothelium|endothelial]] cells and [[Enterocyte|enterocytes]] of the [[small intestine]].<ref>{{Cite journal|last=Hamming|first=I.|last2=Timens|first2=W.|last3=Bulthuis|first3=M. L. C.|last4=Lely|first4=A. T.|last5=Navis|first5=G. J.|last6=Goor|first6=H. van|date=2004|title=Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis|journal=The Journal of Pathology|language=en|volume=203|issue=2|pages=631–637|doi=10.1002/path.1570|pmid=15141377|issn=1096-9896}}</ref> The virus has been found in the faeces of as many as 53%<ref name=":11" /> of hospitalised people and more anal swab positives have been found than oral swab positives in the later stages of infection.<ref name=":13">{{Cite journal|last=Zhang|first=Wei|last2=Du|first2=Rong-Hui|last3=Li|first3=Bei|last4=Zheng|first4=Xiao-Shuang|last5=Yang|first5=Xing-Lou|last6=Hu|first6=Ben|last7=Wang|first7=Yan-Yi|last8=Xiao|first8=Geng-Fu|last9=Yan|first9=Bing|last10=Shi|first10=Zheng-Li|last11=Zhou|first11=Peng|date=1 January 2020|title=Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes|journal=Emerging Microbes & Infections|volume=9|issue=1|pages=386–389|doi=10.1080/22221751.2020.1729071|pmc=7048229|pmid=32065057}}</ref> The virus was found in faeces from 1 to 12 days and 17% of patients continued to present the virus in faeces after no longer presenting them in respiratory samples, indicating that the viral gastrointestinal infection and the potential fecal-oral transmission can last even after viral clearance in the respiratory tract.<ref name=":11" /> Reoccurrence of the virus has also been detected through anal swabs suggesting a shift from more oral positive during the early stages of the disease to more anal positive during later periods.<ref name=":13" />

The virus is thought to be natural and have an [[zoonosis|animal origin]],<ref>{{cite journal | vauthors = Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, etal |title=Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin |date=23 January 2020 |journal=[[bioRxiv]] |type=preprint |doi=10.1101/2020.01.22.914952 |doi-access=free | name-list-format = vanc}}</ref><ref name="NM-20200317">{{cite journal | vauthors = Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF |title=The proximal origin of SARS-CoV-2 |url=https://www.nature.com/articles/s41591-020-0820-9 |date=17 March 2020 |journal=[[Nature Medicine]] |pages=1–3 |doi=10.1038/s41591-020-0820-9 |access-date=18 March 2020 }}</ref> through [[spillover infection]].<ref>{{Cite web|url=http://nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming|title=The Man Who Saw the Pandemic Coming|last=Berger|first=Kevin| name-list-format = vanc |date=12 March 2020|website=Nautilus|access-date=16 March 2020}}</ref> The origin is unknown but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.<ref name="Epidemiology2020Feb17">{{cite journal|vauthors=Yanping Z, et al.|collaboration=The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team|title=The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020|url=http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|journal=China CDC Weekly|volume=2|issue=8|pages=113–122|date=17 February 2020|publisher=[[Chinese Center for Disease Control and Prevention]]|access-date=18 March 2020}}</ref><ref name="Heymann Shindo 2020 pp. 542–45">{{cite journal | vauthors=Heymann DL, Shindo N | title=COVID-19: what is next for public health? | journal=Lancet | volume=395 | issue=10224 | date=February 2020 | pmid=32061313 | doi=10.1016/S0140-6736(20)30374-3 | doi-access=free | pages=542–45 }}</ref> The earliest known infection occurred on 17 November 2019 in [[2019–20 coronavirus pandemic in Hubei|Wuhan, China]].<ref>{{cite news |author=Davidson, Helen |date= 13 March 2020|title= First Covid-19 case happened in November, China government records show—report |url= https://www.theguardian.com/world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report |work=The Guardian|access-date=21 March 2020}}</ref>

<gallery widths="200px" heights="160px">
ဝှာင်:Novel Coronavirus SARS-CoV-2.jpg|ဗီုရုပ် ဝဳရုသ် SARS-CoV-2 မဂွံဆဵုကေတ် ပ္ဍဲမာက္ကရဝ်သကောပ်။ ဍောတ်တ် မတိတ်ဒၟံင်ဂှ် မတုပ်ညံင် ၝောအ်ကိုဋ်၊ ဒုင်သဇိုင် ကုအရာဏအ်တုဲ ဝဳရုသ်ဏအ် ညးကော်စ ကဝ်ရဝ်နာ မဂွံအဓိပ္ပါယ် ၝောအ်ကိုဋ်။ 
ဝှာင်:Coronavirus virion structure.svg|ရုပ်ဓဇက် ဗီုလဒက်ပတန် ကဝ်ရဝ်နာဝဳရုသ် မထ္ၜးလဝ် အရာမနွံ ပ္ဍဲကဵု ဝဳရုသ်မွဲမ မပ္တံကဵု S, spike protein; M, membrane protein; E, envelope protein; N, nucleocapsid protein; structural proteins of coronavirus.
</gallery>

== Diagnosis ==
[[ဝှာင်:CDC_2019-nCoV_Laboratory_Test_Kit.jpg|thumb|CDC rRT-PCR test kit for COVID-19<ref>{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html|title=CDC Tests for 2019-nCoV|date=5 February 2020}}</ref>]]
<gallery widths="300px" heights="110px">
ဝှာင်:COVID19CT2.webp|Typical CT imaging findings
ဝှာင်:COVID19CT1.webp|CT imaging of rapid progression stage
</gallery>

== Prevention ==
[[ဝှာင်:Covid-19-curves-graphic-social-v3.gif|thumb|An illustration of the effect of spreading out infections over a long period of time, known as flattening the curve; decreasing peaks allows healthcare services to better manage the same volume of patients.<ref>{{Cite web|title=The three phases of Covid-19 – and how we can make it manageable|url=https://thespinoff.co.nz/society/09-03-2020/the-three-phases-of-covid-19-and-how-we-can-make-it-manageable/|date=9 March 2020}}</ref><ref name="Lancet2020Flatten">{{Cite journal|title=How will country-based mitigation measures influence the course of the COVID-19 epidemic?|date=March 2020}}</ref><ref>{{Cite web|url=https://www.vox.com/2020/3/10/21171481/coronavirus-us-cases-quarantine-cancellation|title=How canceled events and self-quarantines save lives, in one chart|date=10 March 2020}}</ref>]]
<gallery widths="300px" heights="200px">
ဝှာင်:Covid-19-Transmission-graphic-01.gif|Prevention efforts are multiplicative, with effects far beyond that of a single spread. Each avoided case leads to more avoided cases down the line, which in turn can stop the outbreak in its tracks.
ဝှာင်:COVID19 W ENG.ogv|Handwashing instructions
</gallery>

== Management ==
[[ဝှာင်:DonningCDC2020.jpg|thumb|Four steps to putting on personal protective equipment<ref>{{Cite web|title=Sequence for Putting On Personal Protective Equipment (PPE)|url=https://www.cdc.gov/hai/pdfs/ppe/PPE-Sequence.pdf}}</ref>]]

== Prognosis ==
 
{| class="wikitable"
|+
! colspan="10" |Case fatality rates (%) by age and country
|-
!Age
!0–9
!10–19
!20–29
!30–39
!40–49
!50–59
!60–69
!70–79
!80+
|-
|China as of 11 February<ref name="Epidemiology2020Feb17">{{Cite journal|title=The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020|url=http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|date=17 February 2020}}</ref>
|0.0
|0.2
|0.2
|0.2
|0.4
|1.3
|3.6
|8.0
|14.8
|-
|Italy as of 19 March
|0.0
|0.0
|0.0
|0.4
|0.6
|1.2
|4.9
|15.3
|23.6
|-
|South Korea as of 23 March
|0.0
|0.0
|0.0
|0.1
|0.1
|0.4
|1.6
|6.3
|11.6
|-
|Spain as of 22 March
|0.0
|0.5
|0.3
|0.1
|0.3
|0.6
|2.2
|5.2
|17.9
|}
{| class="wikitable"
|+
! colspan="8" |Case fatality rates (%) by age in the United States
|-
|Age
|0-19
|20-44
|45-54
|55-64
|65-74
|75-84
|≥85
|-
|United States as of 16 March<ref name=":14">{{Cite web|url=https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm|title=Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020|date=16 March 2020|publisher=[[Centers for Disease Control]]}}</ref>
|0.0
|0.1-0.2
|0.5-0.8
|1.4-2.6
|2.7-4.9
|4.3-10.5
|10.4-27.3
|-
| colspan="8" |<small>Note: The lower bound includes all cases. The upper bound excludes cases that were missing data.</small>
|}
<gallery mode="packed" heights="210">
ဝှာင်:Total-cases-covid-19-who.png|Total confirmed cases over time
ဝှာင်:Total-deaths-covid-19-who (1).png|Total deaths over time
ဝှာင်:Total-confirmed-cases-of-covid-19-per-million-people.png|Total confirmed cases of COVID-19 per million people, 20 March 2020<ref>{{cite web |title=Total confirmed cases of COVID-19 per million people |url=https://ourworldindata.org/grapher/total-confirmed-cases-of-covid-19-per-million-people |website=Our World in Data |access-date=20 March 2020}}</ref>
ဝှာင်:Total-covid-deaths-per-million.png|Total confirmed deaths due to COVID-19 per million people, 24 March 2020<ref>{{cite web |title=Total confirmed deaths due to COVID-19 per million people |url=https://ourworldindata.org/grapher/total-covid-deaths-per-million |website=Our World in Data |access-date=24 March 2020}}</ref>
</gallery>

== Terminology ==

=== Passive antibody therapy ===

== နိဿဲ ==
